Pravastatin Sandoz
HMG-CoA Reductase Inhibitor (Statin) for Cholesterol Reduction
Quick Facts About Pravastatin Sandoz
Key Takeaways About Pravastatin Sandoz
- Proven cardiovascular protection: Pravastatin significantly reduces the risk of heart attack, stroke, and cardiovascular death in patients with high cholesterol or established coronary artery disease
- Fewer drug interactions: As a hydrophilic statin not metabolised by CYP3A4, pravastatin has fewer clinically significant drug interactions than lipophilic statins like simvastatin or atorvastatin
- Report muscle symptoms immediately: Unexplained muscle pain, tenderness, or weakness could indicate a rare but serious side effect (rhabdomyolysis) – contact your doctor without delay
- Not safe during pregnancy: Pravastatin must not be used during pregnancy or breastfeeding as it may harm the developing foetus
- Best taken in the evening: Cholesterol production peaks overnight, so taking pravastatin in the evening maximises its effectiveness
What Is Pravastatin Sandoz and What Is It Used For?
Pravastatin Sandoz is a cholesterol-lowering medicine belonging to the statin class (HMG-CoA reductase inhibitors). It reduces the body's production of LDL (“bad”) cholesterol and increases levels of HDL (“good”) cholesterol. It is prescribed to lower the risk of heart attacks, strokes, and other cardiovascular events in patients with high cholesterol or established heart disease.
Pravastatin belongs to a group of medicines called HMG-CoA reductase inhibitors, commonly known as statins. These drugs work by blocking the enzyme HMG-CoA reductase, which plays a key role in the body's cholesterol production in the liver. By inhibiting this enzyme, pravastatin reduces the amount of cholesterol manufactured by the liver and stimulates the liver to absorb more LDL cholesterol from the bloodstream, effectively lowering total and LDL cholesterol levels.
Cholesterol is a fatty substance that circulates in the blood. While the body needs some cholesterol for normal cell function, excessive levels of LDL cholesterol can accumulate in the walls of blood vessels, forming deposits called atherosclerotic plaques. Over time, these plaques narrow and harden the arteries (a process known as atherosclerosis), restricting blood flow to vital organs. If a plaque ruptures, it can trigger a blood clot that blocks a coronary artery (causing a heart attack) or a cerebral artery (causing a stroke).
Pravastatin Sandoz is indicated for the following conditions:
- Primary hypercholesterolaemia: To lower elevated total cholesterol and LDL cholesterol in patients whose levels have not responded adequately to diet and lifestyle changes alone
- Secondary prevention of cardiovascular events: In patients who have had a previous heart attack or who have unstable angina (chest pain at rest), pravastatin reduces the risk of further heart attacks, strokes, and cardiovascular death, regardless of baseline cholesterol levels
- Primary prevention of cardiovascular events: In patients with high cholesterol but no prior history of coronary artery disease, pravastatin reduces the risk of developing coronary events and heart attacks
- Post-organ transplantation: To lower elevated blood lipid levels in patients receiving immunosuppressive therapy (such as cyclosporine) following organ transplantation
When you are prescribed Pravastatin Sandoz, your doctor will also recommend lifestyle modifications as an essential part of your treatment. These include following a heart-healthy diet low in saturated fats and cholesterol, engaging in regular physical exercise, achieving a healthy weight, and stopping smoking if applicable. Pravastatin works alongside these measures to provide comprehensive cardiovascular risk reduction.
Pravastatin is classified as a moderate-intensity statin, typically lowering LDL cholesterol by 25–35% at standard doses. It is one of the most well-studied statins, with large-scale clinical trials (WOSCOPS, CARE, LIPID) involving over 20,000 patients demonstrating its benefits in both primary and secondary cardiovascular prevention. Pravastatin is included on the World Health Organization's Model List of Essential Medicines.
What Should You Know Before Taking Pravastatin Sandoz?
Before starting Pravastatin Sandoz, inform your doctor about all your medical conditions, especially liver disease, kidney disease, thyroid problems, and any history of muscle disorders. Do not use Pravastatin Sandoz during pregnancy or breastfeeding. Tell your doctor about all medications you are currently taking.
Contraindications
You should not take Pravastatin Sandoz if any of the following apply to you:
- Allergy to pravastatin sodium or any of the other ingredients in this medicine – symptoms may include rash, itching, swelling, or difficulty breathing
- Active liver disease or unexplained persistently elevated liver enzymes (transaminases) in blood tests – your doctor will check your liver function before starting treatment
- Pregnancy or if there is a possibility you may become pregnant – cholesterol and other products of the cholesterol synthesis pathway are essential for normal foetal development
- Breastfeeding – pravastatin is excreted in breast milk and could potentially affect the nursing infant
- Existing liver problems that have not been fully investigated and resolved
If you are unsure whether any of these conditions apply to you, consult your doctor before taking Pravastatin Sandoz.
Warnings and Precautions
Talk to your doctor or pharmacist before taking Pravastatin Sandoz if you have or have had any of the following conditions:
- Kidney disease or underactive thyroid (hypothyroidism) – these conditions can increase the risk of muscle-related side effects from statins
- Alcohol problems (regular heavy drinking) – excessive alcohol consumption increases the risk of liver damage when combined with statins
- Hereditary muscle disease (in yourself or a close family member) – this may predispose you to muscle problems with statin therapy
- Previous muscle side effects from another statin or fibrate medication – you may be at higher risk of experiencing similar problems with pravastatin
- Myasthenia gravis or ocular myasthenia (diseases causing muscle weakness) – statins may occasionally worsen these conditions or trigger their onset
- Previous liver problems – your doctor will need to assess whether statin therapy is appropriate for you
- Severe respiratory impairment – inform your doctor about any significant lung conditions
- Current or recent use of fusidic acid (an antibiotic taken orally or by injection) within the past 7 days – the combination of fusidic acid with pravastatin can cause serious muscle damage (rhabdomyolysis)
If any of these conditions apply to you, your doctor may need to perform blood tests before and during treatment with Pravastatin Sandoz. These tests help evaluate your risk of muscle-related side effects and monitor your liver function. Additional blood tests may also be required if you are over 70 years of age.
Contact your doctor immediately if you experience unexplained or persistent muscle pain, tenderness, weakness, or cramps while taking Pravastatin Sandoz, especially if accompanied by fever or general malaise. In very rare cases, these symptoms can indicate a serious condition called rhabdomyolysis, which involves severe muscle breakdown and can lead to life-threatening kidney damage. Your doctor will arrange a blood test (creatine kinase) to assess the situation.
During treatment with Pravastatin Sandoz, your doctor will also monitor you for diabetes, as statins may slightly increase the risk of developing diabetes, particularly if you have risk factors such as elevated blood sugar, high triglycerides, overweight, or high blood pressure.
In a small number of patients, statins can affect the liver. This is detected through routine blood tests that measure liver enzyme levels. Your doctor will typically arrange liver function tests before starting treatment and periodically during therapy.
Use in Children and Adolescents (8–18 years)
Pravastatin may be used in children and adolescents aged 8 to 18 years with heterozygous familial hypercholesterolaemia, a hereditary condition that causes very high cholesterol levels from birth. In children before puberty, the benefits and risks of treatment should be carefully evaluated by a specialist doctor before starting therapy. The decision to treat should take into account the child's overall cardiovascular risk profile, family history, and response to dietary measures.
Pregnancy and Breastfeeding
Pravastatin Sandoz must not be used during pregnancy. Cholesterol and other products of the cholesterol biosynthesis pathway are essential for normal foetal development. Since pravastatin inhibits cholesterol synthesis, it could potentially harm the developing foetus. If you are a woman of childbearing age, your doctor will carefully consider this before prescribing pravastatin and will explain the associated risks.
If you discover that you are pregnant while taking Pravastatin Sandoz, stop the medication immediately and contact your doctor. Effective contraception should be used throughout treatment.
Pravastatin Sandoz must not be used while breastfeeding because small amounts of pravastatin are excreted in breast milk. If you need cholesterol-lowering treatment while breastfeeding, discuss alternative options with your doctor.
Driving and Operating Machinery
Pravastatin Sandoz does not usually affect your ability to drive or operate machinery. However, dizziness, blurred vision, or double vision may occasionally occur during treatment. If you experience any of these symptoms, do not drive or use machines until the effects have resolved. Always exercise caution, as individual responses to medication vary.
Important Information About Ingredients
Lactose: Pravastatin Sandoz tablets contain lactose (milk sugar). If you have been told by your doctor that you have an intolerance to certain sugars, contact your doctor before taking this medicine.
Sodium: This medicine contains less than 1 mmol (23 mg) sodium per tablet, meaning it is essentially “sodium-free” and is suitable for patients on a sodium-restricted diet.
How Does Pravastatin Sandoz Interact with Other Drugs?
Pravastatin Sandoz can interact with several medications, including fibrates, cyclosporine, fusidic acid, certain antibiotics, and anticoagulants. Always tell your doctor about all medications you are taking, including over-the-counter products and herbal supplements. As a hydrophilic statin, pravastatin has fewer CYP-mediated drug interactions than lipophilic statins.
Pravastatin is distinctive among statins because it is hydrophilic (water-soluble) and is not significantly metabolised by the cytochrome P450 (CYP) enzyme system, particularly CYP3A4. This means it has fewer drug interactions compared to lipophilic statins such as simvastatin, atorvastatin, and lovastatin. However, clinically important interactions can still occur, and you should inform your doctor about all medicines you are taking.
Major Interactions
| Drug | Category | Effect | Recommendation |
|---|---|---|---|
| Fusidic acid (oral/IV) | Antibiotic | Combination can cause severe muscle damage (rhabdomyolysis) | Stop pravastatin during fusidic acid treatment; restart 7 days after last dose |
| Cyclosporine | Immunosuppressant | Increases pravastatin blood levels and risk of muscle toxicity | Start with 20 mg pravastatin; maximum 40 mg under close monitoring |
| Gemfibrozil / Fenofibrate | Fibrate (lipid-lowering) | Significantly increased risk of myopathy and rhabdomyolysis | Avoid combination where possible; if necessary, use lowest doses with close monitoring |
| Nicotinic acid (niacin) | Lipid-lowering | Increased risk of muscle problems when combined with statins | Use combination cautiously; report any muscle symptoms immediately |
Moderate Interactions
| Drug | Category | Effect | Recommendation |
|---|---|---|---|
| Erythromycin / Clarithromycin / Roxithromycin | Macrolide antibiotics | May increase pravastatin levels and risk of muscle side effects | Monitor for muscle symptoms during concurrent use |
| Cholestyramine / Colestipol | Bile acid sequestrants | Reduces pravastatin absorption if taken simultaneously | Take pravastatin at least 1 hour before or 4 hours after the resin |
| Rifampicin | Antibiotic (TB treatment) | Can increase pravastatin blood levels via altered hepatic uptake | Take pravastatin at least 2 hours before rifampicin |
| Warfarin and other vitamin K antagonists | Anticoagulants | Pravastatin may enhance anticoagulant effect, altering INR values | Monitor INR closely when starting or stopping pravastatin |
| Colchicine | Anti-gout medication | Increased risk of muscle problems (myopathy) | Use combination with caution; monitor for muscle symptoms |
| Lenalidomide | Immunomodulator | Increased risk of muscle problems when combined with statins | Monitor for muscle symptoms during concurrent use |
Pravastatin Sandoz can be taken with or without food. If you regularly consume large amounts of alcohol, inform your doctor, as excessive alcohol intake combined with statin therapy increases the risk of liver damage.
What Is the Correct Dosage of Pravastatin Sandoz?
The usual adult dose of Pravastatin Sandoz is 10–40 mg once daily, preferably taken in the evening. Your doctor will determine the correct dose for you based on your cholesterol levels, cardiovascular risk, and overall health. Always take this medicine exactly as prescribed.
Always take Pravastatin Sandoz exactly as your doctor or pharmacist has told you. Do not change your dose without consulting your doctor first. The tablet should be swallowed with half a glass of water and can be taken with or without food. The tablet is scored and can be divided into two equal halves if needed.
Adults
Standard Dosing
Starting dose: 10–40 mg once daily, preferably in the evening
Maximum dose: 40 mg once daily
Your doctor will typically start you on 10 or 20 mg and adjust the dose after 4 weeks based on your blood lipid response. Taking pravastatin in the evening is recommended because the liver produces the most cholesterol during the night, and evening dosing maximises the drug's effectiveness.
Secondary Prevention (After Heart Attack or Unstable Angina)
Usual dose: 40 mg once daily
If you have had a heart attack or experience chest pain at rest (unstable angina), your doctor will typically prescribe the higher dose to maximise cardiovascular protection, regardless of your current cholesterol levels.
Children and Adolescents (8–18 years)
Heterozygous Familial Hypercholesterolaemia Only
Ages 8–13 years: 10–20 mg once daily
Ages 14–18 years: 10–40 mg once daily
Use in children is restricted to those with an inherited condition causing very high cholesterol levels and should be supervised by a specialist doctor experienced in managing paediatric lipid disorders.
Patients with Kidney or Liver Impairment
Reduced Kidney or Liver Function
Starting dose: 10 mg once daily
Patients with reduced kidney or liver function should begin treatment at a lower dose. Your doctor will determine whether dose increases are appropriate based on your response and tolerability.
Organ Transplant Recipients
Post-Transplant Lipid Management
Starting dose: 20 mg once daily (may be increased to 40 mg)
If you are taking immunosuppressive medicines such as cyclosporine following an organ transplant, your doctor will start you on 20 mg daily. The dose may be increased to 40 mg under close medical supervision, with regular monitoring of lipid levels and muscle symptoms.
Timing with Bile Acid Sequestrants
If you also take a cholesterol-lowering resin such as cholestyramine or colestipol, you should take Pravastatin Sandoz at least 1 hour before or 4 hours after the resin. This is because the resin can bind to pravastatin and reduce its absorption if taken too close together.
Duration of Treatment
Your doctor will tell you how long to continue taking Pravastatin Sandoz. This medication is typically prescribed for long-term use – often for many years or indefinitely – as its cardiovascular protective benefits depend on sustained treatment. Do not stop taking the medication without your doctor's approval, even if you feel well, as high cholesterol usually has no symptoms.
Missed Dose
If you forget to take a dose, do not worry. Simply skip the missed dose and take your next dose at the usual time. Do not take a double dose to make up for the one you missed. If you frequently forget doses, consider setting a daily reminder.
Overdose
If you have taken more Pravastatin Sandoz than prescribed, or if a child has accidentally ingested the medication, contact your doctor, hospital, or poison control centre immediately for risk assessment and advice. There is no specific antidote for pravastatin overdose. Treatment is supportive, and your doctor will monitor you for any adverse effects.
What Are the Side Effects of Pravastatin Sandoz?
Like all medicines, Pravastatin Sandoz can cause side effects, although not everybody gets them. The most commonly reported side effects include dizziness, headache, digestive disturbances, and muscle or joint pain. Rarely, serious muscle damage (rhabdomyolysis) can occur. Report any unexplained muscle symptoms to your doctor immediately.
Most side effects of pravastatin are mild and may improve as your body adjusts to the medication. However, some side effects require immediate medical attention. If any side effect becomes severe or persistent, consult your doctor or pharmacist.
- Swelling of the face, lips, mouth, tongue, eyes, or throat; difficulty swallowing; hives; or difficulty breathing – these are symptoms of a serious allergic reaction (angioedema, anaphylaxis)
- Unexplained or persistent muscle pain, tenderness, weakness, or cramps, especially if accompanied by fever or general malaise – this could indicate rhabdomyolysis, a very rare but potentially life-threatening condition
- Yellowing of the skin or whites of the eyes, loss of appetite, and feeling generally unwell, or abdominal pain – these may indicate serious liver or pancreatic inflammation
Uncommon
May affect up to 1 in 100 people
- Dizziness, headache
- Sleep disturbances, insomnia
- Visual disturbances (blurred vision, double vision)
- Digestive problems: heartburn, abdominal pain or discomfort, nausea, vomiting, diarrhoea, constipation, flatulence
- Skin reactions: rash, itching, urticaria (hives), scalp or hair changes including hair loss
- Urination changes (difficulty emptying the bladder, frequent urination, nighttime urinary urgency)
- Sexual dysfunction
- Fatigue
- Muscle and joint pain
- Tendon inflammation, which may in rare cases progress to tendon rupture
Rare
May affect up to 1 in 1,000 people
- Increased skin sensitivity to sunlight (photosensitivity)
Very Rare
May affect up to 1 in 10,000 people
- Tingling or numbness in the hands and feet (peripheral neuropathy)
- Allergic condition with joint pain, rash, and fever (lupus erythematosus-like syndrome)
- Muscle pain or weakness (myopathy), muscle inflammation (myositis or polymyositis)
- Abnormal liver blood tests: increased transaminase levels
- Skin and muscle inflammation (dermatomyositis)
Frequency Not Known
Cannot be estimated from available data
- Persistent muscle weakness
- Lichenoid skin rash
- Myasthenia gravis (disease causing generalised muscle weakness, sometimes including breathing muscles)
- Ocular myasthenia (muscle weakness affecting the eyes)
- Muscle rupture
If you experience weakness in your arms or legs that worsens after periods of activity, double vision or drooping eyelids, difficulty swallowing, or shortness of breath, contact your doctor as these may indicate myasthenia gravis.
Side Effects Reported with Statins as a Class
The following side effects have been reported with some statins and may potentially occur with Pravastatin Sandoz:
- Nightmares and vivid dreams
- Memory loss – usually reversible upon discontinuation
- Depression
- Breathing difficulties including persistent cough, shortness of breath, or fever (possible interstitial lung disease)
- Diabetes – this is more likely if you have elevated blood sugar, high triglycerides, overweight, or high blood pressure; your doctor will monitor you during treatment
If you experience any side effects not listed here, or if any side effect becomes severe, contact your doctor or pharmacist. Reporting suspected side effects helps ensure ongoing monitoring of the medicine's benefit-risk balance.
How Should You Store Pravastatin Sandoz?
Store Pravastatin Sandoz tablets in their original packaging at room temperature, protected from moisture. Keep out of the reach and sight of children. Do not use after the expiry date printed on the carton and blister.
Keep Pravastatin Sandoz in its original blister packaging to protect the tablets from moisture, as they are moisture-sensitive. Check the expiry date (marked “EXP” on the carton and blister) before taking any tablets. The expiry date refers to the last day of the stated month.
Do not flush unused tablets down the toilet or dispose of them in household waste. Return any unused or expired medication to your local pharmacy for safe disposal. Proper medication disposal protects the environment from pharmaceutical contamination of water systems and soil.
What Does Pravastatin Sandoz Contain?
Each Pravastatin Sandoz 20 mg tablet contains 20 mg of pravastatin sodium as the active ingredient, along with inactive ingredients including microcrystalline cellulose, lactose monohydrate, and iron oxide (brown) colouring. The tablets are light brown, speckled, oval, and scored on both sides.
Active Ingredient
The active substance is pravastatin sodium. Each 20 mg tablet contains 20 mg of pravastatin sodium. Pravastatin works by inhibiting HMG-CoA reductase, the enzyme responsible for cholesterol synthesis in the liver.
Inactive Ingredients (Excipients)
The other ingredients are: microcrystalline cellulose, lactose monohydrate, anhydrous disodium phosphate, croscarmellose sodium, sodium lauryl sulfate, povidone K25, iron oxide brown (E172), colloidal anhydrous silica, and magnesium stearate. These are standard pharmaceutical excipients used to ensure proper tablet formation, stability, and disintegration.
Tablet Appearance and Packaging
20 mg tablets: Light brown, speckled, oval tablets, scored on both sides and marked with “P 20” on one side. The score line allows the tablet to be divided into two equal halves.
Available in aluminium/aluminium blister packs of 1, 7, 10, 14, 20, 21, 28, 30, 50, 60, 90, 98, 100, and 100×1 tablets. Not all pack sizes may be marketed in your country.
Manufacturer
Marketing authorisation holder: Sandoz A/S, Copenhagen, Denmark. Manufactured by: Lek Pharmaceuticals d.d., Lendava, Slovenia.
How Does Pravastatin Work in the Body?
Pravastatin works by competitively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. This reduces hepatic cholesterol production, causing the liver to upregulate LDL receptors on its surface, which increases LDL cholesterol clearance from the blood. Pravastatin is unique among statins for its hydrophilic nature, which contributes to its favourable drug interaction profile.
The body produces cholesterol primarily in the liver through a complex biochemical pathway. The key step in this pathway is the conversion of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) to mevalonate, catalysed by the enzyme HMG-CoA reductase. Pravastatin is a structural analogue of HMG-CoA and competitively binds to the active site of this enzyme, blocking its activity and reducing the rate of cholesterol production.
When intrahepatic cholesterol levels fall, the liver compensates by increasing the number of LDL receptors on its cell surface. These receptors capture LDL cholesterol particles circulating in the blood, drawing them into the liver for metabolism and excretion. The net result is a significant reduction in both total cholesterol and LDL cholesterol in the bloodstream. Pravastatin also moderately reduces triglyceride levels and modestly increases HDL cholesterol (the “good” cholesterol that helps remove cholesterol from artery walls).
Hydrophilic Properties
Pravastatin is distinctly hydrophilic (water-soluble), in contrast to most other statins which are lipophilic (fat-soluble). This hydrophilicity means that pravastatin does not freely cross cell membranes into non-hepatic tissues. Instead, it is actively transported into the liver by organic anion transporting polypeptides (OATPs). This liver-selective action is thought to contribute to a lower incidence of muscle-related side effects compared to some lipophilic statins. It also means that pravastatin is not significantly metabolised by the CYP3A4 enzyme system, resulting in fewer pharmacokinetic drug interactions.
Pharmacokinetic Profile
After oral administration, pravastatin is rapidly absorbed from the gastrointestinal tract. Peak plasma concentrations are reached approximately 1–1.5 hours after dosing. The oral bioavailability is approximately 17%, reflecting extensive first-pass metabolism in the liver, which is the intended site of action. The elimination half-life is 1.5–2 hours, which is shorter than many other statins. Despite this short half-life, pravastatin remains clinically effective with once-daily dosing because its primary action occurs within the liver, where it persistently reduces cholesterol synthesis.
Approximately 70% of the absorbed dose is eliminated via the faeces (through bile), with about 20% excreted by the kidneys. Pravastatin is approximately 50% protein-bound in the blood, considerably less than lipophilic statins (which are typically >95% protein-bound). This low protein binding further contributes to its favourable drug interaction profile.
Frequently Asked Questions About Pravastatin Sandoz
Pravastatin Sandoz is used to lower elevated cholesterol levels and reduce the risk of cardiovascular events such as heart attacks and strokes. It is prescribed for patients with primary hypercholesterolaemia, for secondary prevention in patients with existing heart disease or previous heart attack, and for managing elevated lipids in organ transplant recipients. It works by reducing the liver's production of LDL (“bad”) cholesterol and increasing HDL (“good”) cholesterol.
The most commonly reported side effects include dizziness, headache, sleep disturbances, visual disturbances (blurred or double vision), digestive problems (heartburn, abdominal pain, nausea, diarrhoea, constipation, flatulence), skin reactions (rash, itching, hives), urination changes, fatigue, and muscle or joint pain. Most side effects are mild and may improve over time as your body adjusts to the medication.
Pravastatin Sandoz should be taken once daily, preferably in the evening, with half a glass of water. It can be taken with or without food. Evening dosing is recommended because cholesterol production in the liver is highest during the night, making the drug most effective when taken at bedtime. Take it at the same time each day for a consistent effect.
No. Pravastatin Sandoz must not be used during pregnancy or breastfeeding. Cholesterol and related compounds are essential for normal foetal development, and inhibiting their production could potentially harm the baby. If you are pregnant or planning to become pregnant, inform your doctor immediately. If you discover you are pregnant while taking pravastatin, stop the medication right away and contact your doctor.
Contact your doctor without delay if you experience unexplained or persistent muscle pain, tenderness, weakness, or cramps, particularly if accompanied by fever or general malaise. In very rare cases, statins can cause rhabdomyolysis – a serious condition involving severe muscle breakdown that can lead to kidney damage. Your doctor will perform a blood test to measure creatine kinase (CK) levels and determine whether you should continue, reduce the dose, or stop taking the medication.
Pravastatin is a hydrophilic (water-soluble) statin, which sets it apart from lipophilic statins like simvastatin and atorvastatin. Because it is not significantly metabolised by the CYP3A4 enzyme system, pravastatin has fewer clinically important drug interactions. This makes it a particularly suitable choice for patients taking multiple medications. Pravastatin is considered a moderate-intensity statin, typically lowering LDL cholesterol by 25–35%, compared to the 40–60% achieved by high-intensity statins like atorvastatin or rosuvastatin.
References
This article is based on the following international medical guidelines and peer-reviewed sources. All medical claims have evidence level 1A, the highest quality of evidence based on systematic reviews of randomised controlled trials.
- Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1):111–188. doi:10.1093/eurheartj/ehz455
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology. 2019;73(24):e285–e350.
- Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia (WOSCOPS). New England Journal of Medicine. 1995;333(20):1301–1307.
- Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels (CARE). New England Journal of Medicine. 1996;335(14):1001–1009.
- The LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels (LIPID). New England Journal of Medicine. 1998;339(19):1349–1357.
- National Institute for Health and Care Excellence (NICE). Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE guideline [CG181]. Updated 2023.
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd list. Geneva: WHO; 2023.
- European Medicines Agency (EMA). Pravastatin – Summary of Product Characteristics. EMA product information database. Accessed January 2026.
- British National Formulary (BNF). Pravastatin sodium. NICE BNF monograph. Accessed January 2026.
Editorial Team
This article has been written and reviewed by the iMedic Medical Editorial Team, a group of licensed specialist physicians with expertise in cardiology, clinical pharmacology, and internal medicine.
Medical Writers
Board-certified physicians specialising in cardiovascular medicine and clinical pharmacology with documented academic and clinical experience.
Medical Reviewers
Independent review board ensuring clinical accuracy, adherence to international guidelines (ESC, AHA, NICE, WHO), and evidence level 1A standards.
All content follows the GRADE evidence framework and is reviewed against current international guidelines. We have no commercial funding or pharmaceutical sponsorship. For more information, see our editorial standards and medical team pages.